ProShares UltraPro Nasdaq Biotechnology (UBIO)

Add to Watchlists
Create an Alert
42.34 +0.22  +0.52% NASDAQ Sep 25, 20:00 Delayed 2m USD
View Full Chart
UBIO Price Chart
View All UBIO News

UBIO News

UBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 5.90% 5.96% -- --
3M 26.16% 26.18% -- --
6M 37.69% 37.67% -- --
YTD 25.86% 25.80% -- --
1Y 11.69% 11.69% -- --
3Y -4.43% -4.31% -- --
5Y -- -- -- --
10Y -- -- -- --
As of Sept. 25, 2018. Returns for periods of 1 year and above are annualized.

UBIO Asset Allocation

Type % Net % Long % Short
Cash -200.0% 36.42% 236.4%
Stock 63.58% 63.58% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 236.4% 236.4% 0.00%
As of Aug. 31, 2018
View More Holdings

UBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Bank Of America Na 109.4% -- --
-- Nasdaq Biotechnology Index Swap Ubs Ag 97.73% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 23.63% -- --
-- Nasdaq Biotechnology Index Swap Goldman Sachs International 5.66% -- --
BIIB Biogen Inc 5.44% 343.09 +0.42%
GILD Gilead Sciences Inc 5.09% 75.65 +0.88%
AMGN Amgen Inc 5.03% 206.98 +0.25%
CELG Celgene Corp 5.02% 88.00 +0.49%
ILMN Illumina Inc 3.83% 363.27 +1.19%
REGN Regeneron Pharmaceuticals Inc 3.07% 389.21 -0.22%
As of Aug. 31, 2018
Advertisement

UBIO Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
300.0%

UBIO Manager Info

Name Tenure
Devin Sullivan 1.92 yrs
Michael Neches 3.20 yrs
Tarak Davé 0.34 yrs

UBIO Net Fund Flows

1M 2.236M
3M -12.54M
6M -11.49M
YTD -21.63M
1Y -21.84M
3Y 1.091M
5Y --
10Y --
As of Aug. 31, 2018

UBIO Risk Info

Beta (5Y) 4.244
Max Drawdown (All) 84.16%
Historical Sharpe (10Y) --
Historical Sortino (All) 0.0539
30-Day Rolling Volatility 42.59%
Daily Value at Risk (VaR) 1% (All) 12.19%
Monthly Value at Risk (VaR) 1% (All) 48.98%

UBIO Comparables

Edit

UBIO Attributes

Key Dates
Inception Date 6/22/2015
Termination Date
Last Annual Report Date 5/31/2018
Last Prospectus Date
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

UBIO Excel Add-In Codes

  • Name: =YCI("UBIO","name")
  • Broad Asset Class: =YCI("UBIO", "broad_asset_class")
  • Broad Category: =YCI("UBIO", "broad_category_group")
  • Prospectus Objective: =YCI("UBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.